Salt of carbostyril formic acid compound as well as preparation method and application of salt

A methoxyquinolone formic acid and compound technology, which is applied to the salt of 8-methoxyquinolone formic acid compounds, the application field of moxifloxacin hydrochloride quality detection and analysis, can solve the problem of affecting the quality of moxifloxacin hydrochloride and increase clinical Drug risks, undisclosed determination of moxifloxacin, etc.

Active Publication Date: 2012-07-18
NANJING YOUKE BIOLOGICAL MEDICAL RES +2
View PDF1 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But, do not disclose to measure the impurity F contained in moxifloxacin with external standard method in the prior art (formula the indicated compound or its salt) method
[0012] Since this related substance exists in moxifloxacin hydrochloride, but the existing detection and analysis methods do not accurately detect and control this related substance, it will inevitably affect the quality of moxifloxacin hydrochloride, increasing the clinical the risks of drug use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Salt of carbostyril formic acid compound as well as preparation method and application of salt
  • Salt of carbostyril formic acid compound as well as preparation method and application of salt
  • Salt of carbostyril formic acid compound as well as preparation method and application of salt

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Example 1 Mode Synthesis of the hydrochloride salt of the compound

[0048] (1), N-methyl-(S,S)-2,8-diazabicyclo[4,3,0]nonane ( d )Synthesis

[0049]

[0050] Measure 30g formula a The compound was dissolved in 200ml of dry dichloromethane, and 46.5g of di-tert-butyl dicarbonate (Boc 2 O) A solution in 50 ml of dichloromethane. Stir at room temperature for 3 h, concentrate under reduced pressure to remove the solvent, and use dichloromethane-methanol (20:1) as the eluent to separate the residue by silica gel column chromatography, collect the product, concentrate under reduced pressure to remove the solvent, and add the residue to Dissolve 100ml of dichloromethane, add dropwise a solution of 35g of iodomethane dissolved in 50ml of dichloromethane at room temperature, stir at room temperature for 2 hours, concentrate under reduced pressure and evaporate the solvent, add 50ml of methanol to the residue to dissolve, add dropwise methanolic hydrochloric acid ...

Embodiment 2

[0057] Example 2 Mode Synthesis of the sodium salt of the compound

[0058] (1), N-methyl-(S,S)-2,8-diazabicyclo[4,3,0]nonane ( d )Synthesis

[0059] Measure 10g formula a The compound was dissolved in 100ml of dry dichloromethane, and 15.5g of di-tert-butyl dicarbonate (Boc 2 O) A solution in 15 ml of dichloromethane. Stir at room temperature for 5 hours, concentrate under reduced pressure to remove the solvent, and use dichloromethane-methanol (20:1) as the eluent to separate the residue by silica gel column chromatography, collect the product, concentrate under reduced pressure to remove the solvent, and add the residue to Dissolve 35ml of dichloromethane, add dropwise a solution of 8.8g dimethyl sulfate dissolved in 15ml of dichloromethane at room temperature, stir at room temperature for 3h, concentrate under reduced pressure and evaporate the solvent, add 20ml methanol to the residue to dissolve, add dropwise methanol hydrochloric acid solution (2ml Conce...

Embodiment 3

[0064] Example 3 Mode mesylate of compound

[0065] (1), N-methyl-(S,S)-2,8-diazabicyclo[4,3,0]nonane ( d )Synthesis

[0066] Measure 10g formula a The compound was dissolved in 100ml of dry dichloromethane, and 15.5g of di-tert-butyl dicarbonate (Boc 2 O) A solution in 15 ml of dichloromethane. Stir at room temperature for 5 hours, concentrate under reduced pressure to remove the solvent, and use dichloromethane-methanol (20:1) as the eluent to separate the residue by silica gel column chromatography, collect the product, concentrate under reduced pressure to remove the solvent, and add the residue to Dissolve 35ml of dichloromethane, add dropwise a solution of 6.3g dimethyl carbonate dissolved in 15ml of dichloromethane at room temperature, stir at room temperature for 5h, concentrate under reduced pressure and evaporate the solvent, add 20ml of methanol to the residue to dissolve, add dropwise methanolic hydrochloric acid solution (2ml Dissolve concentrated ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to an N-methylated 8-methoxyl carbostyril formic acid compound, acid addition salt or alkali metal salt shown in the formula I, as well as a preparation method and an application in quality detection and analysis of moxifloxacin hydrochloride. The compound or salt thereof is taken as an impurity reference substance, and moxifloxacin hydrochloride is detected and analyzed through an external standard method, so that moxifloxacin hydrochloride raw materials produced industrially and the impurity possibly contained in a preparation can be controlled quantificationally, further the quality of moxifloxacin hydrochloride can be increased, and the security in clinical medication can be improved. The formula I is shown in the description.

Description

technical field [0001] The present invention relates to the technical field of pharmaceuticals, in particular to a salt of N-methylated 8-methoxyquinolone formic acid compound, a preparation method of the salt and the performance of the salt in the quality detection and analysis of moxifloxacin hydrochloride application. technical background [0002] Moxifloxacin hydrochloride is an extended-spectrum quinolone antibiotic developed by Bayer Pharmaceuticals. Its chemical name is: 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7- [(4αS,7αS)-octahydro-6 H -Pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride, Cas No.: 151096-09-2, has the chemical structure shown in the following formula . [0003] [0004] Moxifloxacin hydrochloride was launched in Germany for the first time in September 1999, and was approved by the FDA in the United States in December of the same year. Moxifloxacin hydrochloride has broad-spectrum antibacterial activity, especially ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D471/04G01N30/02G01N30/06
Inventor 叶海晁阳曹卫姚洛芫张晓猛刘春猛
Owner NANJING YOUKE BIOLOGICAL MEDICAL RES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap